Showing 1 – 3 of 3
Relevance | Newest | Oldest |
  • JAMA Otolaryngology鈥揌ead & Neck Surgery Original Investigation
    November 23, 2022

    Deescalating Follow-up After Hemithyroidectomy for Patients With Low-risk Papillary Thyroid Microcarcinoma

    Sam P. J.听van Dijk,聽BSc; Hannelore I.听Coerts,聽BSc; Ivona聽Lon膷ar,聽BSc; Cornelis聽Verhoef,聽MD, PhD; Schelto聽Kruijff,聽MD, PhD; Anton F.听Engelsman,聽MD, PhD; Robin P.听Peeters,聽MD, PhD; Tessa M.听van Ginhoven,聽MD, PhD
    Abstract Full Text
    free access
    JAMA Otolaryngol Head Neck Surg. 2022; 149(1):42-48. 10.1001/jamaoto.2022.3686

    This national cohort study assesses the occurrence and risk factors of recurrent disease in all Dutch patients with papillary thyroid microcarcinoma who received surgical treatment according to the Dutch guideline between January 2000 and December 2020.

  • JAMA Otolaryngology鈥揌ead & Neck Surgery Comment & Response
    June 2, 2022

    Radiofrequency Ablation for Papillary Microcarcinoma of the Thyroid鈥擱eply

    Sam P. J.听van Dijk,聽BSc; Hannelore I.听Coerts,聽BSc; Tessa M.听van Ginhoven,聽MD, PhD
    Abstract Full Text
    JAMA Otolaryngol Head Neck Surg. 2022; 148(7):698-699. 10.1001/jamaoto.2022.1177
  • JAMA Otolaryngology鈥揌ead & Neck Surgery Original Investigation
    February 10, 2022

    Assessment of Radiofrequency Ablation for Papillary Microcarcinoma of the Thyroid: A Systematic Review and Meta-analysis

    Sam P. J.听van Dijk,聽BSc; Hannelore I.听Coerts,聽BSc; Sabrina T. G.听Gunput,聽PhD; Evert F. S.听van Velsen,聽MD, MSc; Marco聽Medici,聽MD, PhD; Adriaan聽Moelker,聽MD, PhD; Robin P.听Peeters,聽MD, PhD; Cornelis聽Verhoef,聽MD, PhD; Tessa M.听van Ginhoven,聽MD, PhD
    Abstract Full Text
    free access
    JAMA Otolaryngol Head Neck Surg. 2022; 148(4):317-325. 10.1001/jamaoto.2021.4381

    This systematic review and meta-analysis evaluates the effectiveness and safety of radiofrequency ablation for low-risk papillary microcarcinoma of the thyroid.